#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Older adults represent a growing population using cannabis for symptom management, yet they often lack reliable medical guidance and rely on peer recommendations instead of evidence-based information. Clinicians need to actively screen for and discuss cannabis use with older patients to understand dosing, product types, and potential drug interactions, since edibles pose particular risks including delayed onset of effects that may lead to overconsumption. Establishing clinical protocols for cannabis counseling in geriatric populations can improve safety outcomes while filling the education gap currently left to informal social networks.
A study from University of Utah Health and University of Colorado Boulder found that older adults frequently initiate cannabis use based on informal peer recommendations rather than professional medical guidance, with edibles being a commonly chosen product form. This reliance on word-of-mouth information is particularly concerning given the unique pharmacokinetics of edibles, which have delayed onset and prolonged effects that may pose greater risks for falls, drug interactions, and overdose in aging populations with multiple comorbidities. The research highlights a significant gap in clinical engagement, as many older adults are self-treating conditions without discussion with their healthcare providers who could assess appropriateness, counsel on safer administration methods, and monitor for adverse effects. Clinicians should proactively inquire about cannabis use during patient encounters with older adults, particularly those with chronic pain or other conditions commonly self-treated with cannabis, and provide evidence-based guidance on dosing, product selection, and potential medication interactions.
“What concerns me clinically is that older adults are adopting cannabis products through informal social networks rather than evidence-based consultation, which means we’re seeing dosing errors, drug interactions with their other medications, and delayed detection of adverse effects that could have been prevented with proper medical guidance.”
💊 While word-of-mouth recommendations drive cannabis edible use among older adults, clinicians should recognize that peer endorsements often lack scientific grounding and may not account for age-related pharmacokinetic changes, polypharmacy interactions, or individual health vulnerabilities in this population. Edibles present particular risks for older users given their delayed and variable onset, which can lead to accidental overdosing when patients redose before effects appear, combined with higher sensitivity to cannabinoid-related cognitive and cardiovascular effects. The reliance on informal social networks rather than clinical guidance suggests many older adults may not be disclosing cannabis use to their healthcare providers or receiving evidence-based dosing information. Clinicians caring for older patients should routinely ask about cannabis use in a nonjudgmental way, educate patients about the pharmacodynamic differences between edibles and other routes, and review potential drug interactions, particularly with sedatives, anticoag
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
